Preimplantation Genetic Testing Market
Report ID: SQMIG35D2364
Report ID: SQMIG35D2364
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2364 |
Region:
Global |
Published Date: January, 2026
Pages:
185
|Tables:
149
|Figures:
70
Global Preimplantation Genetic Testing Market size was valued at USD 943.31 Million in 2024 and is poised to grow from USD 1014.06 Million in 2025 to USD 1808.56 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026–2033).
Surge in prevalence of genetic disorders, rise in infertility rates, advancements in genetic screening technologies, and expansion of IVF infrastructure are primarily boosting the demand for preimplantation of genetic testing going forward.
High incidence of genetic and chromosomal abnormalities such as cystic fibrosis, thalassemia, and Down syndrome is driving up the adoption of early genetic testing and screening. Surge in rates of infertility backed by sedentary lifestyles, stress, environmental toxins, and obesity have resulted in high demand for IVF. Preimplantation of genetic testing plays a crucial role in reducing IVF cycles and improving its success rates. Public awareness about genetic diseases, miscarriage risks, and maternal health is also expected to play a crucial role in promoting preimplantation genetic testing market growth over the coming years. Government initiatives promoting reproductive health and technological innovation in genetic testing are facilitating preimplantation of genetic testing adoption.
On the contrary, high costs of procedures, ethical concerns regarding genetic testing, lack of skilled professionals for testing, and clinical outcome uncertainty are estimated to limit the global preimplantation genetic testing market penetration through 2032 and beyond.
What Role does AI play in Preimplantation Genetic Testing?
Artificial intelligence (AI) and automation are transforming preimplantation genetic testing by improving embryo selection accuracy and workflow efficiency. Machine learning algorithms analyze embryo morphology, genetic data, and time-lapse imaging to predict implantation potential with greater precision. Automated systems minimize human error during genetic sequencing, data interpretation, and biopsy handling. These innovations shorten turnaround times and enhance consistency across laboratories. AI-driven decision support tools also assist clinicians in counseling patients with predictive outcomes. As fertility clinics embrace digital transformation, AI integration is becoming a defining trend, enabling scalable, data-driven, and more reliable PGT applications within modern reproductive medicine worldwide.
Market snapshot - 2026-2033
Global Market Size
USD 877.5 million
Largest Segment
Preimplantation Genetic Screening
Fastest Growth
Preimplantation Genetic Diagnosis
Growth Rate
7.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The consumables segment is estimated to hold the highest global preimplantation genetic testing market share going forward. Repeated purchase of consumables such as assay kits, sample collection devices, and calibrators is helping this segment hold sway over others. High reliance on consumables for any type of drug testing and screening is also expected to further cement the high share of this segment in the future.
On the other hand, the demand for services and other goods is expected to rise at a robust pace over the coming years as per this preimplantation genetic testing market forecast. Need specialized services for drug testing and screening coupled with adoption of innovative preimplantation genetic testing programs help create new business scope.
The urine samples segment is slated to spearhead the global preimplantation genetic testing market revenue generation potential over the coming years. Ease of collection associated with urine samples makes it a preferred sample for preimplantation of genetic testing. Easy detection of a wide range of drugs and non-invasive nature of urine sampling are also expected to help bolster the dominance of this segment over the coming years.
Meanwhile, the use of oral fluid samples for preimplantation genetic testings is slated to rise at a notable pace in the coming. High preference for less invasive drug testing solutions and growing demand for efficient testing solutions are helping create new opportunities for market players in the long run.
To get detailed segments analysis, Request a Free Sample Report
Strong presence of genetic testing companies and high rates of IVF adoption are helping this region lead preimplantation genetic testing demand. Supportive regulations, improved reimbursement policies, and awareness of genetic diseases drive consistent demand for preimplantation genetic testing. Early adoption of advanced genetic technologies, presence of a developed fertility infrastructure, and high acceptance of assisted reproductive technologies (ART) are also cementing the dominance of North America.
Presence of a mature assisted reproductive-technology ecosystem and rising demand for precision reproductive care help make the United States a top market for preimplantation genetic testing solutions. High investments in genetic technology R&D, growing awareness regarding hereditary disorders, and emphasis on improving embryo selection are also cementing the dominance of this country in North America. Marketing of genetic testing as a competitive advantage by fertility clinics is also positioning preimplantation genetic testing as a prerequisite in most fertility cycles.
Rising fertility service utilization and increasing access to advanced reproductive care are primarily augmenting preimplantation genetic testing demand in the country. Increasing trend of delayed parenthood among Canadian couples and provincial funding for IVF and donor-egg cycles are also expected to create new opportunities. Growing number of frozen embryo transfers incorporating PGT for aneuploidy or monogenic disorders, as per Canadian fertility registries also indicate a growth trend.
Growing infertility rates, rising awareness regarding genetic health, and delayed parenthood are forecasted to govern the demand for preimplantation of genetic testing across Asia Pacific. Increasing cultural acceptance of IVF and technological transfer from Western countries are also estimated to create new opportunities for preimplantation of genetic testing companies in this region. Expanding middle-class populations with higher disposable incomes enable greater affordability for fertility treatments.
Japan is a country with one of the lowest fertility rates in the world, which makes it a lucrative market for preimplantation genetic testing companies. Expanding geriatric population and growing number of older women opting for IVF at older ages are creating new opportunities. The evolution of reproductive care attitudes and government support to boost adoption of assistive reproduction technologies (ART) is also estimated to make this a rewarding country in the Asia Pacific region.
Shift in societal norms, expansion of private fertility clinics, and delays in parenthood are helping drive preimplantation genetic testing demand in the country. Growing medical tourism and regional cross-border referrals are also expected to play a crucial role in governing preimplantation genetic testing adoption in South Korea. Rising disposable incomes in younger generations allow willingness to pay for enhanced reproductive outcomes, which positions the preimplantation genetic testing industry for robust growth through 2032 and beyond.
The presence of progressive genetic testing regulations and favorable healthcare reimbursement structures make Europe a lucrative market for preimplantation genetic testing providers. Integration of preimplantation genetic testing into national fertility programs in European countries is also creating new business scope going forward. Europe’s balanced regulatory environment and strong biotechnology ecosystem position it as a mature yet continually evolving preimplantation genetic testing market.
Growing awareness regarding infertility and emphasis on avoiding genetic disorders are helping drive preimplantation genetic testing adoption in the country. Late childbearing, recurrent miscarriages, and acceptance of genetic counselling in fertility practices are also boosting the demand for preimplantation genetic testing in the United Kingdom over the coming years. The Human Fertilisation & Embryology Authority (HFEA) framework ensures PGT-M and PGT-SR services are licensed, raising visibility of genetic screening options.
Launch of new regulatory frameworks supporting reproductive genetics coupled with a developed healthcare infrastructure makes Germany a key market for preimplantation genetic testing. Germany’s advanced molecular-diagnostic industry and translational research environment ensure accessibility to advanced preimplantation genetic testing solutions and services. The presence of insurance-backed fertility programs and expansive fertility-clinic networks are also ensuring consistent demand for preimplantation genetic testing.
Strong reproductive-health traditions and rising public awareness of genetic disease prevention are helping boost the demand for preimplantation genetic testing in France. The country’s biotechnology and diagnostics industry is also supporting consistent adoption of preimplantation genetic testing going forward. France’s regulatory environment and ethical oversight instill trust in preimplantation genetic services.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Expansion of IVF and Fertility Infrastructure
Technological Advancements in Genetic Screening
High Procedural Costs and Limited Insurance Coverage
Ethical and Regulatory Complexities
Request Free Customization of this report to help us to meet your business objectives.
Preimplantation genetic testing providers should focus on enhancing the efficiency of their products and developing non-invasive testing solutions. Raising awareness regarding substance abuse can also help improve business scope for preimplantation genetic testing providers. Investing in the R&D of novel portable and rapid tests is also a prominent opportunity for companies as per this global preimplantation genetic testing market analysis.
Reducing the test and result times coupled with integration of advanced technologies is slated to help improve efficacy of drug testing. Here’s a startup that has the potential to augment the preimplantation genetic testing industry in the long run.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, a growing incidence of substance abuse and a growing emphasis on preventive care are anticipated to drive the demand for preimplantation genetic testing going forward. However, limited detection windows and ethical concerns regarding drug testing are slated to slow down the adoption of preimplantation genetic testing in the future. North America is slated to spearhead the demand for preimplantation genetic testing owing to high number of drug abuse cases and stringent regulatory requirements. Development of at-home drug testing kits and emphasis on non-invasive testing are anticipated to be key trends driving the preimplantation genetic testing industry through 2032 and beyond.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 943.31 Million |
| Market size value in 2033 | USD 1808.56 Million |
| Growth Rate | 7.5% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Preimplantation Genetic Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Preimplantation Genetic Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Preimplantation Genetic Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Preimplantation Genetic Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
